(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPVEE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPVEE

ST13

US500000098976019

Class

5, 44

Filing

98976019

Registration

7930553

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

09/02/2025

Trademark type

Word

Nice classes

5, 44

Filing date

12/22/2023

Registration date

09/02/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/02/2025

Last transaction

09/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

10/11/2023

First use in commerce

10/11/2023

Drawing code

4

Owner type

03

Owner location

North Chesterfield, VA, US

Examiner

KRUSSMAN, IAN

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Indivior Inc.

Representatives

Shauna M. Wertheim The Marbury Law Group, PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productspharmaceutical preparations for treating opioid overdoses; pharmaceutical preparationan opioid antagonist; nasal sprays for treating opioid overdoses

Class 44

Medical services; health care; medical clinic services; provision of pharmaceutical advice and information about pharmaceuticals used in the treatment and prevention of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosefor the treatment and prevention of co-morbidities associated with substance use disordersfor the treatment and prevention of mental health diseases and disordersfor the treatment and prevention of central nervous system disease and disordersfor the treatment of pain; health counseling; provision of health care information and advice; provision of information and advice relating to the diagnosticprophylactic and therapeutic properties of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/02/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/15/2025

PUBO

PUBLISHED FOR OPPOSITION

07/15/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/09/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/10/2025

DPCC

DIVISIONAL PROCESSING COMPLETE

06/09/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/28/2025

DRRR

DIVISIONAL REQUEST RECEIVED

01/23/2025

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

01/23/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/22/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/22/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/22/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

10/22/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

10/22/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/24/2024

GNRT

NON-FINAL ACTION E-MAILED

07/24/2024

CNRT

NON-FINAL ACTION WRITTEN

07/24/2024

DOCK

ASSIGNED TO EXAMINER

07/24/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/06/2024

NWAP

NEW APPLICATION ENTERED

12/23/2023

Continuous trademark protection

Get notified about every new filing that threatens OPVEE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.